Riskpilot← Back to searchSign inGet full accessNORMEDICAL AS
ASActiveOrg 911855100Drammensveien 50D, 0271 OsloManufacture of medical and dental instruments and supplies · NACE 3250Est. 20130 employees
Revenue 2024
NOK 81K
-89% vs 2023
EBITDA margin
134.9%
-88% vs 2023
Equity ratio
-213117.8%
Financial strength
Net profit 2024
NOK 110K
-89% vs 2023
| Revenue | NOK 81K | -89% |
| EBITDA | NOK 109K | -88% |
| Net profit | NOK 110K | -89% |
| Total assets | NOK 2K | -7% |
| Equity | NOK -3,4M | +16% |
| Employees | 0 | — |
Legal name
NORMEDICAL AS
Org number
911855100
Legal form
Aksjeselskap
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
22. april 2013
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Produksjon av varme- og kuldepakninger til terapeutisk behandling. Handel og agentur, import og eksport, salg av andre varer, samt alt som står i forbindelse med dette, herunder deltagelse i andre selskaper med samme eller lignendeformål. Gjøre alt det nødvendige eller hensiktsmessige for oppfyllelse av de ovennevnte formål eller hva som er forbundet med dem i videste forstand.
Address
Drammensveien 50D, 0271 Oslo
Phone
+4732161790
Email
info@normedical.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 577 | 3 140 | 1 897 | 2 913 | 1 963 | 3 669 | 2 451 | 3 531 | 2 743 | 428 | 737 | 81 |
| Staff expenses | −653 | −1 384 | −897 | −1 098 | −1 488 | −1 734 | −1 123 | −824 | −486 | −16 | −0 | −0 |
| EBITDA | −211 | −589 | −1 501 | 196 | −1 463 | −541 | −1 611 | −385 | −1 663 | 55 | 924 | 109 |
| Depreciation & amort. | −0 | −20 | −20 | −20 | −20 | −31 | −36 | −19 | −0 | −0 | −0 | −0 |
| EBIT | −211 | −609 | −1 521 | 176 | −1 483 | −572 | −1 647 | −403 | −1 663 | 55 | 924 | 109 |
| Net financials | −10 | −106 | −210 | −140 | −262 | −374 | −233 | −100 | −43 | −69 | 105 | 0 |
| Profit before tax | −222 | −716 | −1 731 | 36 | −1 745 | −947 | −1 880 | −503 | −1 705 | −15 | 1 029 | 110 |
| Tax | −60 | −193 | −414 | 35 | −375 | −165 | −414 | −111 | 1 695 | −0 | −0 | −0 |
| Net profit | −162 | −522 | −1 317 | 1 | −1 370 | −782 | −1 466 | −392 | −3 400 | −15 | 1 029 | 110 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 846 | 1 749 | 1 646 | 2 518 | 2 118 | 4 102 | 2 519 | 2 857 | 61 | 21 | 2 | 2 |
| Equity | −132 | −654 | −1 971 | 101 | −1 269 | 147 | −1 319 | −1 711 | −5 111 | −5 126 | −4 097 | −3 440 |
| Long-term debt | 0 | 1 259 | 1 545 | 102 | 2 060 | 700 | 1 794 | 1 586 | 0 | 0 | 0 | 0 |
| Short-term debt | 978 | 1 144 | 2 072 | 2 315 | 1 327 | 3 255 | 2 043 | 2 982 | 5 172 | 5 147 | 4 099 | 3 441 |
| Total debt | 978 | 2 404 | 3 617 | 2 417 | 3 388 | 3 955 | 3 838 | 4 568 | 5 172 | 5 147 | 4 099 | 3 441 |
EBITDA margin
134.9%
This company
15.8%
Market median
+754% vs market
20132024
Equity ratio
-213117.8%
This company
38.2%
Market median
-558000% vs market
20132024
Return on equity
10965100.0%
This company
18.4%
Market median
+59592835% vs market
20132024
Net profit margin
135.2%
This company
8.1%
Market median
+1569% vs market
20132024
Asset turnover
50.24×
This company
1.12×
Market median
+4386% vs market
20132024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20132024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-03-21 – 2013-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2024 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Normedical Group As | Company | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Scientia Invest As
NORMEDICAL AS Board members of NORMEDICAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Frank Loe Nylænde | Chairman | 0 companies |
| Fredrik Ove Haug Ringvold | Chairman | 0 companies |
| Per Torkel Rødland | Board of Directors | 0 companies |